| Ytd | 6.76% | |
| 1y | 17.51% |
| Open | 5.13 | Prev Close | 5.16 | Low | 5.05 | High | 5.21 | Mkt Cap | 446.48M |
| Vol | 200.62K | Avg Vol | 1.12M | EPS | -0.14 | P/E | -36.30 | Forward P/E | N/A |
| Beta | 2.22 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 5.58 | 200-d Avg | 4.99 | 1yr Est | 0.00 |
SRTA News
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the
Strata Critical Medical is rated a buy, driven by expanding market share, operational efficiencies,
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today annou
Network of experienced transplant surgeons in key markets will immediately become available to all S
Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading vol
Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company"))), today anno
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or
Directors bring a strong combination of technology, healthcare, national security, leadership experi
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or
Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $260.000 million-$275.000 mi
Strata Critical Medical (NASDAQ:SRTA) reported quarterly earnings of $0.03 per share which beat the
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today annou
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" o
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the
Ark Invest made no trades in its six main ETFs for two straight days, a rare feat. Here's how th
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” o
Craig-Hallum analyst Bill Bonello initiates coverage on Strata Critical Medical (NASDAQ:SRTA) wit
B. Riley Securities analyst Yuan Zhi initiates coverage on Strata Critical Medical (NASDAQ:SRTA)
Strata Critical Medical is rated 'Buy' with a 12–24 month horizon, targeting 30–35% upside as valuat
Dow falls over 1,100 points as shares of Ingram Micro jump 11.8% on better-than-expected earnings. O
Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $255.000 million-$270.000 mil
Strata Critical Medical (NASDAQ:SRTA) reported quarterly sales of $66.787 million which beat the ana
Revenue increased 83.5% year-over-year to $66.8 million in Q4 2025 Logistics revenue and gross profi
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical (Nasdaq: SRTA, “Strata” or the “
Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), a leading p
$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased
Strata Critical Medical, Inc. is refocused on organ transplant logistics after divesting its air pas
Lake Street analyst Benjamin Haynor assumes Strata Critical Medical (NASDAQ:SRTA) with a Buy rati
Strata Critical Medical, Inc. ( SRTA ) Analyst/Investor Day November 17, 2025 2:00 PM EST Company Pa
NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or
Strata Critical Medical (NASDAQ:SRTA) sees FY2025 sales of $185.000 million-$195.000 million vs $183
Strata Critical Medical (NASDAQ:SRTA) reported quarterly losses of $(0.12) per share which missed th
